These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34220677)

  • 1. Genetic Deletion of mGlu3 Metabotropic Glutamate Receptors Amplifies Ischemic Brain Damage and Associated Neuroinflammation in Mice.
    Mastroiacovo F; Zinni M; Mascio G; Bruno V; Battaglia G; Pansiot J; Imbriglio T; Mairesse J; Baud O; Nicoletti F
    Front Neurol; 2021; 12():668877. PubMed ID: 34220677
    [No Abstract]   [Full Text] [Related]  

  • 2. mGlu3 receptor regulates microglial cell reactivity in neonatal rats.
    Zinni M; Mairesse J; Pansiot J; Fazio F; Iacovelli L; Antenucci N; Orlando R; Nicoletti F; Vaiman D; Baud O
    J Neuroinflammation; 2021 Jan; 18(1):13. PubMed ID: 33407565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
    Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
    Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental abnormalities in cortical GABAergic system in mice lacking mGlu3 metabotropic glutamate receptors.
    Imbriglio T; Verhaeghe R; Martinello K; Pascarelli MT; Chece G; Bucci D; Notartomaso S; Quattromani M; Mascio G; Scalabrì F; Simeone A; Maccari S; Del Percio C; Wieloch T; Fucile S; Babiloni C; Battaglia G; Limatola C; Nicoletti F; Cannella M
    FASEB J; 2019 Dec; 33(12):14204-14220. PubMed ID: 31665922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
    Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
    Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.
    Corti C; Battaglia G; Molinaro G; Riozzi B; Pittaluga A; Corsi M; Mugnaini M; Nicoletti F; Bruno V
    J Neurosci; 2007 Aug; 27(31):8297-308. PubMed ID: 17670976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic deletion of mGlu2 metabotropic glutamate receptors improves the short-term outcome of cerebral transient focal ischemia.
    Mastroiacovo F; Moyanova S; Cannella M; Gaglione A; Verhaeghe R; Bozza G; Madonna M; Motolese M; Traficante A; Riozzi B; Bruno V; Battaglia G; Lodge D; Nicoletti F
    Mol Brain; 2017 Aug; 10(1):39. PubMed ID: 28821279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
    Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD
    Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic?
    Caraci F; Battaglia G; Sortino MA; Spampinato S; Molinaro G; Copani A; Nicoletti F; Bruno V
    Neurochem Int; 2012 Sep; 61(4):559-65. PubMed ID: 22306345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand.
    Taylor DL; Jones F; Kubota ES; Pocock JM
    J Neurosci; 2005 Mar; 25(11):2952-64. PubMed ID: 15772355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus.
    Linden AM; Baez M; Bergeron M; Schoepp DD
    Neuropharmacology; 2006 Aug; 51(2):213-28. PubMed ID: 16733060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mGlu
    Joffe ME; Santiago CI; Oliver KH; Maksymetz J; Harris NA; Engers JL; Lindsley CW; Winder DG; Conn PJ
    Neuron; 2020 Jan; 105(1):46-59.e3. PubMed ID: 31735403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of group II metabotropic glutamate receptors by G protein-coupled receptor kinases: mGlu2 receptors are resistant to homologous desensitization.
    Iacovelli L; Molinaro G; Battaglia G; Motolese M; Di Menna L; Alfiero M; Blahos J; Matrisciano F; Corsi M; Corti C; Bruno V; De Blasi A; Nicoletti F
    Mol Pharmacol; 2009 Apr; 75(4):991-1003. PubMed ID: 19164443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice.
    Jiang MQ; Zhao YY; Cao W; Wei ZZ; Gu X; Wei L; Yu SP
    Brain Pathol; 2017 Jul; 27(4):480-498. PubMed ID: 27514013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
    Fell MJ; Svensson KA; Johnson BG; Schoepp DD
    J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented β2-adrenergic signaling dampens the neuroinflammatory response following ischemic stroke and increases stroke size.
    Lechtenberg KJ; Meyer ST; Doyle JB; Peterson TC; Buckwalter MS
    J Neuroinflammation; 2019 May; 16(1):112. PubMed ID: 31138227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt canonical pathway activator TWS119 drives microglial anti-inflammatory activation and facilitates neurological recovery following experimental stroke.
    Song D; Zhang X; Chen J; Liu X; Xue J; Zhang L; Lan X
    J Neuroinflammation; 2019 Dec; 16(1):256. PubMed ID: 31810470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
    Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
    Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LXW7 ameliorates focal cerebral ischemia injury and attenuates inflammatory responses in activated microglia in rats.
    Fang T; Zhou D; Lu L; Tong X; Wu J; Yi L
    Braz J Med Biol Res; 2016 Aug; 49(9):e5287. PubMed ID: 27533766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phthalide derivative CD21 alleviates cerebral ischemia-induced neuroinflammation: Involvement of microglial M2 polarization via AMPK activation.
    Gan YM; Liu DL; Chen C; Duan W; Yang YX; Du JR
    Eur J Pharmacol; 2020 Nov; 886():173552. PubMed ID: 32926919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.